日本の組換えタンパク質市場レポート：製品、用途、エンドユーザー、地域別、2025年～2033年

日本の組換えタンパク質市場の市場規模は2024年に2億6,570万米ドルに達しました。IMARC Groupは、2025年から2033年にかけての成長率（CAGR）は9％で、2033年には5億7,660万米ドルに達すると予測しています。モノクローナル抗体、ワクチン、治療用タンパク質など、がん、自己免疫疾患、感染症などさまざまな疾患の治療に使用されるようになっているバイオ医薬品の開発が市場を牽引しています。

本レポートで扱う主な質問

• 日本の組換えタンパク質市場のこれまでの業績と、今後数年間の業績は？
• COVID-19の日本の組換えタンパク質市場への影響は？
• 日本の組換えタンパク質市場の製品別構成比は？
• 日本の組換えタンパク質市場の用途別内訳は？
• 日本の組換えタンパク質市場のエンドユーザー別の内訳は？
• 日本の組換えタンパク質市場のバリューチェーンにはどのような段階がありますか？
• 日本における組換えタンパク質の主要な促進要因と課題は何か？
• 日本の組換えタンパク質市場の構造と主要プレーヤーは？
• 日本の組換えタンパク質市場における競合の程度は？

目次

第1章 序文

第2章 調査範囲と調査手法

• 調査の目的
• ステークホルダー
• データソース
• 市場推定
• 調査手法

第3章 エグゼクティブサマリー

第4章 日本の組換えタンパク質市場-イントロダクション

• 概要
• 市場力学
• 業界動向
• 競合情報

第5章 日本の組換えタンパク質市場情勢

• 過去および現在の市場動向（2019年～2024年）
• 市場予測（2025年～2033年）

第6章 日本の組換えタンパク質市場- 製品別内訳

• 抗体
• ホルモン
• 成長因子
• サイトカイン
• その他

第7章 日本の組換えタンパク質市場- 用途別の内訳

• 医薬品の発見と開発
• 学術研究
• バイオテクノロジー調査
• バイオ医薬品製造
• その他

第8章 日本の組換えタンパク質市場- エンドユーザー別の内訳

• 製薬・バイオ医薬品企業
• バイオテクノロジー企業
• 学術研究機関
• 契約研究機関
• その他

第9章 日本の組換えタンパク質市場-競合情勢

• 概要
• 市場構造
• 市場プレーヤーのポジショニング
• 主要成功戦略
• 競合ダッシュボード
• 企業評価象限

第10章 主要企業のプロファイル

第11章 日本の組換えタンパク質市場- 業界分析

• 促進要因・抑制要因・機会
• ポーターのファイブフォース分析
• バリューチェーン分析

第12章 付録

Japan recombinant protein market size reached USD 265.7 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 576.6 Million by 2033, exhibiting a growth rate (CAGR) of 9% during 2025-2033. The inflating development of biopharmaceuticals, such as monoclonal antibodies, vaccines, and therapeutic proteins, which are increasingly being used to treat various illnesses, including cancer, autoimmune disorders, and infectious diseases, is driving the market.

Recombinant protein are artificially engineered proteins created by combining genetic material from different sources, typically DNA from one organism with the ability to produce a specific protein and the host organism's cellular machinery for protein production. This process is integral to the biotechnology and pharmaceutical industries, allowing the large-scale production of specific proteins for various applications. To create recombinant proteins, scientists insert the desired gene sequence into a host organism, like bacteria, yeast, or mammalian cells. Once the host organism takes up the foreign DNA, it begins producing the target protein according to the inserted genetic instructions. Recombinant proteins have diverse applications, including the production of therapeutic drugs (e.g., insulin or vaccines), research tools (e.g., enzymes and antibodies), and industrial enzymes for various processes (e.g., biofuel production or food processing). Their production allows for precise control, scalability, and purity, making them essential in advancing medical, scientific, and industrial fields.

Japan Recombinant Protein Market Trends:

Several factors drive the recombinant protein market in Japan. Firstly, the increasing incidence of chronic diseases such as cancer, diabetes, and autoimmune disorders has created a growing demand for therapeutic proteins produced through recombinant DNA technology. Consequently, pharmaceutical companies are heavily investing in the development of novel biopharmaceuticals, propelling the market forward. Furthermore, advancements in genetic engineering and biotechnology have led to improved production processes for recombinant proteins. Enhanced expression systems, such as mammalian and yeast cell lines, have enabled the production of complex proteins with higher yields and better quality, driving market expansion. In addition to this, the surge in R&D activities in the field of proteomics and genomics has boosted the demand for recombinant proteins as research tools. These proteins are essential for studying gene function, protein-protein interactions, and drug discovery, fostering market growth. Moreover, the adoption of personalized medicine and the development of bi-specific antibodies and fusion proteins, which have opened up new opportunities in the therapeutic protein industry, is expected to drive the recombinant protein market in Japan during the forecast period.

Japan Recombinant Protein Market Segmentation:

Product Insights:

• Antibodies
• Hormones
• Growth Factors
• Cytokines
• Others

Application Insights:

• Drug Discovery and Development
• Academic Research
• Biotechnology Research
• Biopharmaceutical Production
• Others

End User Insights:

• Pharmaceutical and Biopharmaceutical Companies
• Biotechnology Companies
• Academic and Research Institutes
• Contract Research Organization
• Others

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

• How has the Japan recombinant protein market performed so far and how will it perform in the coming years?
• What has been the impact of COVID-19 on the Japan recombinant protein market?
• What is the breakup of the Japan recombinant protein market on the basis of product?
• What is the breakup of the Japan recombinant protein market on the basis of application?
• What is the breakup of the Japan recombinant protein market on the basis of end user?
• What are the various stages in the value chain of the Japan recombinant protein market?
• What are the key driving factors and challenges in the Japan recombinant protein?
• What is the structure of the Japan recombinant protein market and who are the key players?
• What is the degree of competition in the Japan recombinant protein market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Japan Recombinant Protein Market - Introduction

• 4.1 Overview
• 4.2 Market Dynamics
• 4.3 Industry Trends
• 4.4 Competitive Intelligence

5 Japan Recombinant Protein Market Landscape

• 5.1 Historical and Current Market Trends (2019-2024)
• 5.2 Market Forecast (2025-2033)

6 Japan Recombinant Protein Market - Breakup by Product

• 6.1 Antibodies
  • 6.1.1 Overview
  • 6.1.2 Historical and Current Market Trends (2019-2024)
  • 6.1.3 Market Forecast (2025-2033)
• 6.2 Hormones
  • 6.2.1 Overview
  • 6.2.2 Historical and Current Market Trends (2019-2024)
  • 6.2.3 Market Forecast (2025-2033)
• 6.3 Growth Factors
  • 6.3.1 Overview
  • 6.3.2 Historical and Current Market Trends (2019-2024)
  • 6.3.3 Market Forecast (2025-2033)
• 6.4 Cytokines
  • 6.4.1 Overview
  • 6.4.2 Historical and Current Market Trends (2019-2024)
  • 6.4.3 Market Forecast (2025-2033)
• 6.5 Others
  • 6.5.1 Historical and Current Market Trends (2019-2024)
  • 6.5.2 Market Forecast (2025-2033)

7 Japan Recombinant Protein Market - Breakup by Application

• 7.1 Drug Discovery and Development
  • 7.1.1 Overview
  • 7.1.2 Historical and Current Market Trends (2019-2024)
  • 7.1.3 Market Forecast (2025-2033)
• 7.2 Academic Research
  • 7.2.1 Overview
  • 7.2.2 Historical and Current Market Trends (2019-2024)
  • 7.2.3 Market Forecast (2025-2033)
• 7.3 Biotechnology Research
  • 7.3.1 Overview
  • 7.3.2 Historical and Current Market Trends (2019-2024)
  • 7.3.3 Market Forecast (2025-2033)
• 7.4 Biopharmaceutical Production
  • 7.4.1 Overview
  • 7.4.2 Historical and Current Market Trends (2019-2024)
  • 7.4.3 Market Forecast (2025-2033)
• 7.5 Others
  • 7.5.1 Historical and Current Market Trends (2019-2024)
  • 7.5.2 Market Forecast (2025-2033)

8 Japan Recombinant Protein Market - Breakup by End User

• 8.1 Pharmaceutical and Biopharmaceutical Companies
  • 8.1.1 Overview
  • 8.1.2 Historical and Current Market Trends (2019-2024)
  • 8.1.3 Market Forecast (2025-2033)
• 8.2 Biotechnology Companies
  • 8.2.1 Overview
  • 8.2.2 Historical and Current Market Trends (2019-2024)
  • 8.2.3 Market Forecast (2025-2033)
• 8.3 Academic and Research Institutes
  • 8.3.1 Overview
  • 8.3.2 Historical and Current Market Trends (2019-2024)
  • 8.3.3 Market Forecast (2025-2033)
• 8.4 Contract Research Organization
  • 8.4.1 Overview
  • 8.4.2 Historical and Current Market Trends (2019-2024)
  • 8.4.3 Market Forecast (2025-2033)
• 8.5 Others
  • 8.5.1 Historical and Current Market Trends (2019-2024)
  • 8.5.2 Market Forecast (2025-2033)

9 Japan Recombinant Protein Market - Competitive Landscape

• 9.1 Overview
• 9.2 Market Structure
• 9.3 Market Player Positioning
• 9.4 Top Winning Strategies
• 9.5 Competitive Dashboard
• 9.6 Company Evaluation Quadrant

10 Profiles of Key Players

• 10.1 Company A
  • 10.1.1 Business Overview
  • 10.1.2 Product Portfolio
  • 10.1.3 Business Strategies
  • 10.1.4 SWOT Analysis
  • 10.1.5 Major News and Events
• 10.2 Company B
  • 10.2.1 Business Overview
  • 10.2.2 Product Portfolio
  • 10.2.3 Business Strategies
  • 10.2.4 SWOT Analysis
  • 10.2.5 Major News and Events
• 10.3 Company C
  • 10.3.1 Business Overview
  • 10.3.2 Product Portfolio
  • 10.3.3 Business Strategies
  • 10.3.4 SWOT Analysis
  • 10.3.5 Major News and Events
• 10.4 Company D
  • 10.4.1 Business Overview
  • 10.4.2 Product Portfolio
  • 10.4.3 Business Strategies
  • 10.4.4 SWOT Analysis
  • 10.4.5 Major News and Events
• 10.5 Company E
  • 10.5.1 Business Overview
  • 10.5.2 Product Portfolio
  • 10.5.3 Business Strategies
  • 10.5.4 SWOT Analysis
  • 10.5.5 Major News and Events

11 Japan Recombinant Protein Market - Industry Analysis

• 11.1 Drivers, Restraints, and Opportunities
  • 11.1.1 Overview
  • 11.1.2 Drivers
  • 11.1.3 Restraints
  • 11.1.4 Opportunities
• 11.2 Porters Five Forces Analysis
  • 11.2.1 Overview
  • 11.2.2 Bargaining Power of Buyers
  • 11.2.3 Bargaining Power of Suppliers
  • 11.2.4 Degree of Competition
  • 11.2.5 Threat of New Entrants
  • 11.2.6 Threat of Substitutes
• 11.3 Value Chain Analysis

12 Appendix